삼성서울병원

Ko En

소화기내과 고명지 교수

진료분야
간암, 간경화, 급성간염, 만성간염, 지방간, 간질환, 간이식
진료일정 04 月
날짜
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
오전
오후
진료일정 05 月
날짜
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
오전
오후

학력

학력
2014.02 성균관대학교 의과전문대학원 졸업 (석사)
2010.02 포항공과대학교 생명의학과 졸업

경력

경력
2022.03 ~현재 성균관의대 삼성서울병원 소화기내과 임상조교수
2019.03 ~ 2022.02 성균관의대 삼성서울병원 소화기내과 임상강사
2015.03 ~ 2019.02 삼성서울병원 내과 레지던트
2014.03 ~ 2015.02 삼성서울병원 인턴

학회활동

학회활동
2021.03 ~ 현재 대한간암학회 정회원
2021.03 ~ 현재 대한간학회 정회원
  • NPJ DIGIT MED 2024 10.1038/s41746-023-00976-8 Machine learning-based clinical decision support system for treatment recommendation and overall survival prediction of hepatocellular carcinoma: a multi-center study Lee, KH; Choi, GH; Yun, J; Choi, J; Goh, MJ; Sinn, DH; Jin, YJ; Kim, MA; Yu, SJ; Jang, S; Lee, SK; Jang, JW; Lee, JS; Kim, D; Cho, YY; Kim, HJ; Kim, S; Kim, JH; Kim, N; Kim, KM
    View PubMed
  • RADIOTHER ONCOL 2023 10.1016/j.radonc.2023.109841 External validation of subclassification system and progression pattern analysis in hepatocelluar carcinoma with macroscopic vascular invasion Yu, JI; Park, HC; Shin, H; Park, H; Shin, SW; Cho, SK; Hyun, D; Shin, J; Goh, MJ; Choi, MS; Park, B; Yoon, SM; Jung, JH
    View PubMed
  • JHEP REP 2023 10.1016/j.jhepr.2023.100810 Metabolic dysfunction-associated fatty liver disease and the risk of hepatocellular carcinoma Song, BG; Choi, SC; Goh, MJ; Kang, WS; Sinn, DH; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Paik, SW
    View PubMed
  • LIVER INT 2023 10.1111/liv.15632 Validation of non-invasive diagnosis of CSPH in patients with compensated advanced chronic liver disease according to Baveno VII Song, BG; Goh, MJ; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Paik, SW; Sinn, DH
    View PubMed
  • SCI REP-UK 2023 10.1038/s41598-023-36668-2 Improved on-treatment fibrosis-4 during antiviral therapy and lower hepatocellular carcinoma risk in cirrhotic patients with hepatitis B Oh, JH; Park, Y; Goh, MJ; Sinn, DH; Ahn, SB; Kang, WS; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Paik, SW
    View PubMed
  • CLIN MOL HEPATOL 2023 10.3350/cmh.2022.0404 Clinical practice guideline and real-life practice in hepatocellular carcinoma: A Korean perspective Goh, MJ; Sinn, DH; Kim, JM; Lee, MW; Hyun, DH; Il Yu, J; Hong, JY; Choi, MS
    View PubMed
  • GUT LIVER 2023 10.5009/gnl220420 Clinical Outcomes and Validation of Ursodeoxycholic Acid Response Scores in Patients with Korean Primary Biliary Cholangitis: A Multicenter Cohort Study Chang, JI; Kim, JH; Sinn, DH; Cho, JY; Kim, KM; Oh, JH; Park, Y; Sohn, W; Goh, MJ; Kang, W; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • EUR J GASTROEN HEPAT 2023 10.1097/MEG.0000000000002466 Sorafenib versus nivolumab after lenvatinib treatment failure in patients with advanced hepatocellular carcinoma Kim, Y; Lee, JS; Lee, HW; Kim, BK; Park, JY; Kim, D; Ahn, SH; Goh, MJ; Kang, W; Kim, SU
    View PubMed
  • GUT LIVER 2023 10.5009/gnl220337 Pretransplant Functional Status Predicts Postoperative Morbidity and Mortality after Liver Transplantation in Patients with Cirrhosis Goh, MJ; Kim, J; Chang, WH; Sinn, DH; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW; Kim, JM; Kang, WS
    View PubMed
  • LIVER CANCER 2023 10.1159/000529635 Impact of Intrahepatic External Beam Radiotherapy in Advanced Hepatocellular Carcinoma Patients Treated with Tyrosine Kinase Inhibitors Goh, MJ; Park, HC; Yu, JI; Kang, WS; Gwak, GY; Paik, YH; Lee, JH; Koh, KC; Paik, SW; Sinn, DH; Choi, MS
    View PubMed
  • LIVER CANCER 2022 10.1159/000525145 Real Life Study of Lenvatinib Therapy for Hepatocellular Carcinoma: RELEVANT Study Casadei-Gardini, A; Rimini, M; Kudo, M; Shimose, S; Tada, T; Suda, G; Goh, MJ; Jefremow, A; Scartozzi, M; Cabibbo, G; Campani, C; Tamburini, E; Tovoli, F; Ueshima, K; Aoki, T; Iwamoto, H; Torimura, T; Kumada, T; Hiraoka, A; Atsukawa, M; Itobayashi, E; Toyoda, H; Sakamoto, N; Sho, T; Kang, W; Siebler, J; Neurath, MF; Burgio, V; Cascinu, S
    View PubMed
  • CLIN MOL HEPATOL 2022 10.3350/cmh.2021.0366 Statin and aspirin for chemoprevention of hepato- cellular carcinoma: Time to use or wait further? Goh, MJ; Sinn, DH
    View PubMed
  • FRONT ONCOL 2022 10.3389/fonc.2022.888755 Safety and Efficacy of Liver-Directed Radiotherapy in Combination With Lenvatinib for Hepatocelluar Carcinoma With Macroscopic Tumor Thrombosis Yu, JI; Kang, W; Yoo, GS; Goh, MJ; Sinn, DH; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW; Hong, JY; Lim, HY; Park, B; Park, HC
    View PubMed
  • SCI REP-UK 2022 10.1038/s41598-022-11736-1 Prognostic significance of cachexia index in patients with advanced hepatocellular carcinoma treated with systemic chemotherapy Goh, MJ; Kang, W; Jeong, WK; Sinn, DH; Gwak, GY; Paik, YH; Choi, MS; Lee, JH; Koh, KC; Paik, SW
    View PubMed
  • ESMO OPEN 2021 10.1016/j.esmoop.2021.100330 Nonalcoholic steatohepatitis in hepatocarcinoma: new insights about its prognostic role in patients treated with lenvatinib Rimini, M; Kudo, M; Tada, T; Shigeo, S; Kang, W; Suda, G; Jefremow, A; Burgio, V; Iavarone, M; Tortora, R; Marra, F; Lonardi, S; Tamburini, E; Piscaglia, F; Masi, G; Cabibbo, G; Foschi, FG; Silletta, M; Kumada, T; Iwamoto, H; Aoki, T; Goh, MJ; Sakamoto, N; Siebler, J; Hiraoka, A; Niizeki, T; Ueshima, K; Sho, T; Atsukawa, M; Hirooka, M; Tsuji, K; Ishikawa, T; Takaguchi, K; Kariyama, K; Itobayashi, E; Tajiri, K; Shimada, N; Shibata, H; Ochi, H; Yasuda, S; Toyoda, H; Fukunishi, S; Ohama, H; Kawata, K; Tani, J; Nakamura, S; Nouso, K; Tsutsui, A; Nagano, T; Takaaki, T; Itokawa, N; Okubo, T; Arai, T; Imai, M; Joko, K; Koizumi, Y; Hiasa, Y; Cucchetti, A; Ratti, F; Aldrighetti, L; Cascinu, S; Casadei-Gardini, A
    View PubMed
  • HEPATOLOGY 2020 10.1002/hep.31079 Letter to the Editor: Statins and Reduced Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B REPLY Goh1, MJ; Kim, S; Woo, SY; Sinn, DH
    View PubMed

해당하는 결과가 없습니다.